FTC, lawmakers seek to block reverse payments

05/7/2008 | International Herald Tribune

The Federal Trade Commission and several lawmakers are trying to block reverse payments -- a practice in which major drugmakers pay generic drug companies to delay launching their products -- because they say it violates antitrust rules. U.S. courts, however, seem to be divided over the issue, as drug firms have won two of three cases involving such payoffs. Proposals to prohibit the payments also have been opposed by both brand-name and generic-drug companies and are unlikely to gain the approval of Congress this year.

View Full Article in:

International Herald Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN